News

1.Date of occurrence of the event:2024/07/12

2.Funding recipient name, relationship with lender, lending limit

(thousand NTD), starting outstanding balance (thousand NTD), new loan

(thousand NTD), is it part of a scheduled allocation or revolving limit for

the same recipient that the chairman is authorized by the board of directors

to allocate, outstanding balance (thousand NTD) up to the date of

occurrence, reason for new loan (thousand NTD):

(1)Funding recipient name: LCY BIOTECHNOLOGY HOLDING INC.

(2)Relationship with lender: a subsidiary of the company

(3)Lending limit (thousand NTD): 25,935,205

(4)Starting outstanding balance (thousand NTD): 726,880

(5)New loan (thousand NTD): 68,271

(6)Is it part of a scheduled allocation or revolving limit for the same

  recipient that the chairman is authorized by the board of directors to

  allocate: Yes

(7)Outstanding balance (thousand NTD) up to the date of occurrence: 795,151

(8)Reason for new loan (thousand NTD):For operating.

3.For collaterals provided by the loan recipient, the content and the value

(thousand NTD):

(1)Content of collaterals: Promissory notes of the same amount.

(2)Value of collaterals: 795,151

4.For the latest financial reports of the loan recipient, the capital

(thousand NTD) and the cumulative gains/losses(thousand NTD):

(1)Capital: 209,817

(2)Cumulative gains: -1,119,105

5.Method of calculation of interest: The loan interest is calculated at an

annual rate, accruing from the date of the loan or the interest commencement

date, fixed at 8.5%, with monthly payments.

6.For repayment, the condition and the date: From the date of the loan for a

period of one year.

7.The amount of monetary loans extended to others as of the date of

occurrence (thousand NTD): 38,090,750

8.The total amount of monetary loans extended to others as a percentage of

the public company’s net worth on the latest financial statements as of the

date of occurrence: 1727.49%

9.Sources of funds for the company to extend monetary loans to others: Other

10.Any other matters that need to be specified:

The source of funds for lending to others originates from the company's own

funds. LCY is no longer subject to the Regulations Governing Loaning of Funds

by Public Companies; instead, the matters of fund lending are governed by the

company's internal operational procedures.